BMP4 enhances foam cell formation by BMPR-2/SMAD1/5/8 signaling

International Journal of Molecular Sciences

Volumn 15, Issue 4, 2014, Pages 5536-5552

  Feng, Jun ^a   Gao, Jiangfei ^b   Li, Yuxin ^c   Yang, Yanhua ^d   Dang, Lili ^e   Ye, Yuanpeng ^a   Deng, Jingyuan ^a   Li, Antai ^f  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Shangluo Central Hospital   (China)

^c XI'AN MEDICAL UNIVERSITY   (China)

^d Shaanxi People's Armed Police Corps Hospital   (China)

^e Department of Ophthalmology   (China)

^f XI AN CENTRAL HOSPITAL   (China)

Author keywords

BMP4; BMPR 2; Foam cell formation; Smad1 5 8

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; BETA ACTIN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CD36 ANTIGEN; CHOLESTEROL ESTER; LIPOFECTAMINE; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; SCAVENGER RECEPTOR A; SMAD PROTEIN; SMAD PROTEIN 1; SMAD PROTEIN 5; SMAD PROTEIN 8; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ABC TRANSPORTER; ABCA1 PROTEIN, MOUSE; ABCG1 PROTEIN, MOUSE; BMP4 PROTEIN, MOUSE; BMPR2 PROTEIN, MOUSE; LIPID; LIPOPROTEIN; SMAD1 PROTEIN; SMAD1 PROTEIN, MOUSE; SMAD5 PROTEIN; SMAD5 PROTEIN, MOUSE; SMAD8 PROTEIN; SMAD9 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CHEMOLUMINESCENCE; CHOLESTEROL BLOOD LEVEL; DENSITOMETRY; FOAM CELL; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIPID STORAGE; MACROPHAGE; MOUSE; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLEURA MESOTHELIOMA; SCINTILLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; ATHEROSCLEROTIC PLAQUE; BIOSYNTHESIS; CELL LINE; GENETICS; METABOLISM; PATHOLOGY; RNA INTERFERENCE; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ATHEROSCLEROSIS; ATP BINDING CASSETTE TRANSPORTER 1; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CELL LINE; CHOLESTEROL ESTERS; FOAM CELLS; LIPIDS; LIPOPROTEINS; MICE; PLAQUE, ATHEROSCLEROTIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

EID: 84897422935     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15045536     Document Type: Article

References (34)

1. Davis, N.E. Atherosclerosis-An inflammatory process. J. Insur. Med. 2005, 37, 72-75.
2. Lloyd-Jones, D.; Adams, R.J.; Brown, T.M.; Carnethon, M.; Dai, S.; de Simone, G.; Ferguson, T.B.; Ford, E.; Furie, K.; Gillespie, C. et al. Executive summary: Heart disease and stroke statistics- 2010 update: A report from the American Heart Association. Circulation 2010, 121, 948-954.
3. Falk, E. Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am. J. Cardiol. 1989, 63, 114-120.
4. Kristanto, W.; van Ooijen, P.M.; Jansevan der Weide, M.C.; Vliegenthart, R.; Oudkerk, M. A meta analysis and hierarchical classification of HU-based atherosclerotic plaque characterization criteria. PLoS One 2013, 8, 73460-73472.
5. Ueda, Y.; Matsuo, K.; Nishio, M.; Hirata, A.; Nemoto, T.; Asai, M.; Murakami, A.; Kashiwase, K.; Kodama, K. Systemic and local factors associated with coronary plaque disruption.Thromb. Res. 2012, 129, 164-168.
6. Thies, F.; Garry, J.; Yaqoob, P.; Rerkasem, K.; Williams, J.; Shearman, C.P.; Gallagher, P.J.; Calder, P.C.; Grimble, R.F. Association n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: A randomised controlled trial. Lancet 2003, 361, 477-485.
7. Cawood, A.L.; Ding, R.; Napper, F.L.; Young, R.H.; Williams, J.A.; Ward, M.J.; Gudmundsen, O.; Vige, R.; Payne, S.P.; Ye, S. et al. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis 2010, 212, 252-259.
8. Cheng, F.; Torzewski, M.; Degreif, A.; Rossmann, H.; Canisius, A.; Lackner, K.J. Impact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: Implications for atherogenesis. PLoS One 2013, 8, e72063.
9. Tian, L.; Luo, N.; Zhu, X.; Chung, B.H.; Garvey, W.T.; Fu, Y. Adiponect{stroke}AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: Differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses. Atherosclerosis 2012, 221, 66-75.
10. Yvan, C.L.; Wang, N.; Tall, A.R. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler. Thromb. Vasc. Biol. 2010, 30, 139-143.
11. Finn, A.V.; Nakano, M.; Polavarapu, R.; Karmali, V.; Saeed, O.; Zhao, X.; Yazdani, S.; Otsuka, F.; Davis, T.; Habib, A. et al. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J. Am. Coll. Cardiol. 2012, 59, 166-177.
12. Bragdon, B.; Moseychuk, O.; Saldanha, S.; King D.; Julian, J.; Nohe, A. Bone morphogenetic proteins: A critical review. Cell. Signal. 2011, 23, 609-620.
13. Saeed, O.; Otsuka, F.; Polavarapu, R.; Karmali, V.; Weiss, D.; Davis, T.; Rostad, B.; Pachura, K.; Adams, L.; Elliott, J. et al. Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclero Ar.t erioscler. Thromb. Vasc. Biol. 2012, 32, 299-307.
14. Usas, A.; Ho, A.M.; Cooper, G.M.; Olshanski, A.; Peng, H.; Huard, J. Bone regeneration m ediated by BMP4-expressing muscle-derived stem cells is affected by delivery system. Tissue Eng. Part A 2008, 15, 285-293.
15. Boyd, N.; Dhara, S.; Rekaya, R.; Godbey, E.; Hasneen, K.; Rao, R.; West, F.; Gerwe, B.; Stice, S. BMP4 promotes formation of primitive vascular networks in human embryonic stem cell-derived embryoid bodies. Exp. Biol. Med. 2007, 232, 833-843.
16. Weber, S.; ylor, J.C.; Winyard, P.; Baker, K.F.; Sullivan, B.J.; Schild, R.; Knüppel, T.; Zurowska, A.M.; Caldas-Alfonso, A.; Litwin, M. et al. SIX2 and BMP4 mutations associate with anomalous kidney development. J. Am. Soc. Nephrol. 2008, 19, 891-903.
17. David, L.; Feige, J.J.; Bailly, S. Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev. 2009, 20, 203-212.
18. Shyu, K. Cellular and molecular effects of mechanical stretch on vascular cells and cardiac myocytes. Clin. Sci. 2009, 116, 377-389.
19. Cao, F.; Castrillo, A.; Tontonoz, P.; Re, F.; Byrne, G.I. Chlamydia pn-induoceda e macrophage foam cell formation is mediated by T-llike receptor2. Infect. Immun. 2007, 75, 753-759.
20. Beyea, M.M.; Reaume, S.; Sawyez, C.G.; Edwards, J.Y.; O'Neil, C.; Hegele, R.A.; Pickering, J.G.; Huff, M.W. The oxysterol 24S(),25-epoxycholesterol attenuates human smooth muscl-ederived foam cell formation via reduced low-density lipoprotein uptake and enhanced cholesterol efflux. J. Am. Heart Assoc. 2012, 1, 2047-9980.
21. Imanishi, T.; Akasaka, T. Novel strategies to target inflammatory processes in atherosclerosis. Curr. Pharm. Des. 2013, 19, 1616-1625.
22. Phillips, J.A.; Poling, J.S.; Phillips, C.A.; Stanton, K.C.; Austin, E.D.; Cogan, J.D.; Wheeler, L.; Yu, C.; Newman, J.H.; Dietz, H.C. et al. Synergistic heterozygosity for TGFβ 1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension. Genet. Med. 2008, 10, 359-365.
23. Vanderpool, R.R.; E-Bizri, N.; Rabinovitch, M.; Chesler, N.C. Patchy deletion of Bmpr1a potentiates proximal pulmonary artery remodeling in mice exposed to chronic hypoxia Biomech. Model. Mechanobiol. 2013, 12, 33-42.
24. Watanabe, Y.; Itoh, S.; Goto, T.; Ohnishi, E.; Inamitsu, M.; Itoh, F.; Satoh, K.; Wiercinska, E.; Yang, W.; Shi, L. et al. TMEPAI, a transmembrane TGF-β-inducible protein, sequesters Smad proteins from active participation in TGF-β signaling. Mol. Cell 2010, 37, 123-134.
25. Ten Dijke, P.; Hill, C.S. New insights into TGF-β-Smad signalling. Trends Biochem. Sci. 2004, 29, 265-273.
26. Dewachter, L.; Adnot, S.; Guignabert, C.; Tu, L.; Marcos, E.; Fadel, E.; Humbert, M.; Dartevelle, P.; Simonneau, G.; Naeije, R. et al. Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension. Eur. Respir. J. 2009, 34, 1100-1110.
27. Tarling, E.J.; Vallim, T.Q.; Edwards, P.A. Role of ABC transporters in lipid transport and human disease. Trends Endocrinol. Metab. 2013, 108, 194-200.
28. Pagler, T.A.; Wang, M.; Mondal, M.; Murphy, A.J.; Westerterp, M.; Moore, K.J.; Maxfield, F.R.; Tall, A.R. Deletion of ABCA1 and ABCG1 impairs macrophage migration because of increased rac1 signalingnovelty and significance. Circ. Res. 2011, 108, 194-200.
29. Kruit, J.K.; Wijesekara, N.; Westwell, R.C.; Vanmierlo, T.; de Haan, W.; Bhattacharjee, A.; Tang, R.; Wellington, C.L.; LütJohann, D.; Johnson, J.D. et al. Loss of both ABCA1 and ABCG1 results in increased disturbances in islet sterol homeostasis, inflammation, and impaired β-cell function. Diabetes 2012, 61, 659-664.
30. Pardali, E.; ten Dijke, P. TGFβ signaling and cardiovascular diseases. Int. J. Biol. Sci.2012, 8, 195-213.
31. Helbing, T.; Rothweiler, R.; Ketterer, E.; Goetz, L.; Heinke, J.; Grundmann, S.; Duerschmied, D.; Patterson, C.; Bode, C.; Moser, M. BMP activity controlled by BMPER regulates proinflammatory phenotype of endothelium. Blood 2011, 118, 5040-5049.
32. Wei, Y.; Nazari, J.M.; Chan, L.; Zhu, M.; Heyll, K.; Corbalán, C.J.; Hartmann, P.; Thiemann, A.; Weber, C.; Schober, A. The microR-3 42-5p fosters inflammatory macrophage activation through an Akt1-and microRNA-155-dependent pathway during atherosclerosis. Circulation 2013, 127, 1609-1619.
33. Chen, D.; Zhao, M.; Mundy, G.R. Bone morphogenetic proteGnro wth Factors 2004, 22, 233-241.
34. Lagna, G.; Ku, M.M.; Nguyen, P.H.; Neuman, N.A.; Davis, B.N.; Hata, A. Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through th myocardin-related transcription factors. J. Biol. Chem. 2007, 282, 37244-37255.